Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
PROBIOTICXL Campaign Shows Off Gut Health In Style - Great HealthWorks' fresh, bold and hilarious new campaign celebrates being "regular"
-
Tango Therapeutics Appoints Sung Lee to Board of Directors
-
Alta Equipment Group Announces Preferred Stock Dividend
-
GH Research Announces FDA Lifts Clinical Hold on GH001, Clearing Path for Global Phase 3 Initiation in 2026
-
Lantronix Previews Turnkey Drone Reference Platform to Accelerate Defense and Commercial UAV Development
-
Beneficient Regains Full Compliance with Nasdaq Listing Requirements
-
Copper Quest Acquires 100% Interest in the Kitimat Copper-Gold Project
-
Ceva Enhances NeuPro-Nano NPU Ecosystem with Addition of Sensory's TrulyHandsfree Voice Activation
-
A2Z Cust2Mate Deepens Migros Ticaret A.Ş. Relationship to Transform In-Store Shopping with Smart Carts
-
Bausch Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference
-
Teradar Unveils the World's First Terahertz Vision Sensor Summit to Redefine Automotive Safety and Autonomous Driving at CES
-
RedHill's RHB-102 Progresses in Multiple GI Indications Including GLP-1 Therapy-Related GI Side Effects
-
Arbe Combines Market-Leading Radar Solution with Powerful NVIDIA AI Computing, Creating Advanced Platform for AI-based Driving
-
VIPRE Security Group: AI-Native Malware, Deepfake Fraud-as-a-Service, and IoT Exploits to Drive Enterprise Risk in 2026 -- With Global AI Regulation Accelerating the Urgency of Human-Centric Security
-
AerCap Leased, Purchased and Sold 705 Assets in the Full Year 2025 and 240 Assets in the Fourth Quarter 2025
-
Halozyme and Skye Bioscience Announce Global Collaboration and License Agreement to Evaluate Nimacimab Co-Formulated with ENHANZE® for Obesity
-
Mobileye Surround ADAS Adds Second Top 10 Automaker
-
NewcelX Appoints Dr. Julien Boisdron, a Swiss Big Pharma Leader in Diabetes Innovation, to Its Scientific Advisory Board
-
Nurix Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference
-
SES AI Announces its January 2026 Event Calendar
-
Proteris Compliance Solutions Launches Advanced Forms Management System
-
AE Industrial to Acquire Majority Stake in L3Harris’ Space Propulsion & Power Business – “Rocketdyne”
-
Rx Networks Partners with Zephr.xyz to Scale High-Precision GNSS for Mass-Market Android Devices
-
Stallion Uranium Announces Mobilization for Winter Drilling Program, Appoints Paulo Santos as Chief Financial Officer
-
Nanoscope Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
-
Agios to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026
-
CareTrust Acquires Mid-Atlantic Skilled Nursing Portfolio for Approximately $142 Million
-
Continental Resources Expands Vaca Muerta Position Through Agreement With Pan American Energy
-
Laird Superfood® to Participate in 28th Annual ICR Conference on January 13, 2026
-
Natera Launches 21-Gene Fetal Focus™ Single-Gene NIPT, Powered By Ultra-Sensitive LinkedSNP™ Technology
-
iMDx Prepares for U.S. Commercial Launch of GraftAssureDx as Clinical Trial Nears Completion
-
COOLFLY to Debut the Aura Smart Bird Feeder at CES 2026
-
KORU Medical Systems Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
-
Perion to Participate in the 28th Annual Needham Growth Conference on January 14th, 2026
-
L3Harris to Sell Majority Stake in Space Propulsion & Power Business to AE Industrial Partners
-
Kelun-Biotech Receives Investigational New Drug Approval for ITGB6-Targeted ADC SKB105 from the NMPA
-
SBC Medical Accelerates Global Expansion with Strategic Investment and Alliance with a Leading U.S. MedSpa Platform OrangeTwist as Part of Broader Growth Strategy
-
Seeing Machines to unveil 3D Cabin Perception Mapping at CES2026
-
Comcast Announces Completion of Separation of Versant Media Group, Inc.
-
Takeda and Protagonist Announce Submission of New Drug Application (NDA) for Rusfertide for Treatment of Polycythemia Vera (PV)
-
NaaS Technology Inc. to Hold Extraordinary General Meeting on January 23, 2026
-
Dianthus Therapeutics To Participate in the 44th Annual J.P. Morgan Healthcare Conference
-
ProtoArc to Debut Smart Workspace Concept at CES 2026
-
Cellarity to Present at 44th Annual J.P. Morgan Healthcare Conference
-
Evergold Announces $300,000 Ore Group Financing, Sharpened Focus on Golden Lion Project, Toodoggone District, Northern BC
-
Sibros Launches SDV App Marketplace, Bringing Turnkey Connected Solutions to Automakers and Fleets
-
Seaport Therapeutics to Present at 44th Annual J.P. Morgan Healthcare Conference
-
United Therapeutics Corporation to Present at the 44th Annual J.P. Morgan Healthcare Conference
-
HeartBeam to Attend JP Morgan 2026 Annual Healthcare Conference
-
Bausch + Lomb Partners with Glaucoma Research Foundation and The Glaucoma Foundation to Address a Leading Cause of Irreversible Blindness in the U.S.

